Bevacizumab 100 Milligrams per 4 Milliliters Intravenous Solution Priced at $405.01 at Aurora Sheboygan

Bevacizumab is an advanced intravenous medication commonly used in the treatment of various cancers, including colorectal, lung, kidney, and others. This therapy works by inhibiting the growth of blood vessels that supply nutrients to tumors, thereby slowing or stopping tumor progression. The listed price of $405.01 at Aurora Sheboygan covers a 100 milligram per 4 milliliter formulation and reflects not just the medication itself, but also the specialized handling, preparation, and precise administration required for this type of infusion therapy. Patients are encouraged to request an itemized estimate prior to treatment and verify what is included in the charge, as additional costs (such as facility fees, lab work, or infusion services) may apply.

Cost Breakdown

• Medication: Bevacizumab 100 mg/4 mL intravenous solution – $405.01 per dose
• Administration: Intravenous infusion typically requires professional staff and monitoring (costs may be billed separately)
• Preparation: Pharmacy compounding and safety checks (may be included or itemized)
• Facility Fees: Use of infusion center, equipment, and supplies (often additional)
• Other Possible Charges: Pre-medication, lab tests, and follow-up visits

Insurance & Payment Advice

• Check with your insurance provider about coverage for Bevacizumab, as cancer therapies are often subject to pre-authorization or specific criteria.
• Ask for a detailed, itemized estimate from the medical center to understand which services are included in the quoted fee.
• Discuss payment plans or financial assistance options with the billing department if you anticipate high out-of-pocket costs.

Side Effect Considerations & Recovery Tips

• Common side effects of Bevacizumab can include high blood pressure, fatigue, bleeding, and risk of infection. Serious side effects are possible—report any concerns to your care team promptly.
• After each infusion, follow your care team’s instructions regarding hydration, activity, and monitoring for symptoms.
• Arrange for transportation if needed, as some patients may feel fatigued after treatment.

Frequently Asked Questions

• What conditions is Bevacizumab used to treat?
  Bevacizumab is approved for several types of cancer, including colorectal, lung, kidney, and certain brain tumors, by inhibiting tumor blood vessel growth.
• How is Bevacizumab administered?
  It is given as an intravenous infusion, typically in a clinic or hospital setting under the supervision of medical professionals.
• What does the $405.01 fee include?
  The fee covers one dose of Bevacizumab (100 mg/4 mL). Additional charges for infusion services, facility use, and related care may apply.
• Will my insurance cover Bevacizumab?
  Many insurance plans cover Bevacizumab for approved indications, but coverage varies. Check with your provider and obtain pre-authorization if necessary.
• Are there additional costs beyond the medication itself?
  Yes. Facility fees, infusion charges, lab tests, and doctor visits may not be included in the medication price. Always request an itemized estimate.
• What are the main side effects of Bevacizumab?
  Common side effects include high blood pressure, bleeding, delayed wound healing, and increased risk of infection. Discuss risks with your oncologist.
• How often will I need Bevacizumab infusions?
  The frequency depends on your specific cancer type and treatment plan—typically every 2 or 3 weeks.
• Can I drive myself home after an infusion?
  Many patients are able to, but if you experience fatigue or side effects, arrange for transportation.
• How can I manage costs if I am uninsured or underinsured?
  Speak with the billing office about financial assistance programs, payment plans, or manufacturer support options.
• Should I bring anything with me to my infusion appointment?
  Bring your insurance information, a list of medications, and something to help you stay comfortable (such as a book or music) during the infusion.

Aurora Medical Center Sheboygan County offers a specialized medical service involving the administration of Bevacizumab, a medication used primarily in the treatment of various types of cancer. The specific formulation available is a 100 milligrams per 4 milliliters intravenous solution, priced at $405.01. Bevacizumab works by inhibiting the growth of blood vessels that supply nutrients to tumors, thereby slowing or stopping their growth. This treatment is administered intravenously, meaning it is delivered directly into the bloodstream, allowing for rapid and effective distribution throughout the body. The cost reflects the complexity and precision required in the preparation and administration of this advanced therapeutic option.

What is Bevacizumab used for? – Bevacizumab is used to treat various types of cancer by inhibiting the growth of blood vessels that supply nutrients to tumors.

How is Bevacizumab administered? – Bevacizumab is administered intravenously, meaning it is delivered directly into the bloodstream.

What is the cost of Bevacizumab at Aurora Sheboygan? – The cost of Bevacizumab 100 milligrams per 4 milliliters intravenous solution at Aurora Sheboygan is $405.01.

Why is Bevacizumab priced at $405.01? – The price reflects the complexity and precision required in the preparation and administration of this advanced therapeutic option.

Is Bevacizumab effective for all types of cancer? – Bevacizumab is primarily used for specific types of cancer, and its effectiveness can vary depending on the individual case and cancer type.

Are there any side effects associated with Bevacizumab? – Yes, like many medications, Bevacizumab can have side effects, and patients should discuss potential risks with their healthcare provider.

How long does a Bevacizumab treatment session take? – The duration of a Bevacizumab treatment session can vary, but it typically involves a period of observation following the intravenous administration to monitor for any immediate reactions.

Can Bevacizumab be combined with other treatments? – Bevacizumab is often used in combination with other cancer treatments, and the specific regimen should be determined by a healthcare professional.